Clinical trialNCT00808249CompletedPhase 2Interventional

AZD7325 Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)

SponsorAstraZenecaEnrollment725Anxiety Disorders

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this research study is to determine whether AstraZeneca's drug AZD7325 is safe and effective in the treatment of generalized anxiety disorder.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

David V. Sheehan
University of South Florida College of Medicine
Principal Investigator
clinicaltrials.gov ↗
Mark A. Smith, MD, PhD
AstraZeneca
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

52 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Research Site
Birmingham, Alabama, United States
Research Site
Tucson, Arizona, United States
Research Site
Arcadia, California, United States
Research Site
Beverly Hills, California, United States
Research Site
Cerritos, California, United States
Research Site
Chino, California, United States
Research Site
Encino, California, United States
Research Site
Los Alamitos, California, United States
Research Site
Novato, California, United States
Research Site
Oceanside, California, United States
Research Site
San Diego, California, United States
Research Site
Norwich, Connecticut, United States
Research Site
Fort Myers, Florida, United States
Research Site
Miami, Florida, United States
Research Site
Pembroke Pines, Florida, United States
Research Site
Saint Petersberg, Florida, United States
Research Site
Tampa, Florida, United States
Research Site
Winter Park, Florida, United States
Research Site
Atlanta, Georgia, United States
Research Site
Marietta, Georgia, United States
Research Site
Smyrna, Georgia, United States
Research Site
Libertyville, Illinois, United States
Research Site
Park Ridge, Illinois, United States
Research Site
Indianapolis, Indiana, United States
Research Site
Overland Park, Kansas, United States
Research Site
Baltimore, Maryland, United States
Research Site
Boston, Massachusetts, United States
Research Site
Cambridge, Massachusetts, United States
Research Site
St Louis, Missouri, United States
Research Site
Clementon, New Jersey, United States
Research Site
Fresh Meadows, New York, United States
Research Site
Mount Kisco, New York, United States
Research Site
New York, New York, United States
Research Site
Rochester, New York, United States
Research Site
Raleigh, North Carolina, United States
Research Site
Winston-Salem, North Carolina, United States
Research Site
Bismarck, North Dakota, United States
Research Site
Beechwood, Ohio, United States
Research Site
Cincinnati, Ohio, United States
Research Site
Middleburg Heights, Ohio, United States

12 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

AZD7325Placebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Dec 2008
Primary completion: 31 May 2009
Completion: 31 May 2009
Last update posted: 20 Jun 2011
Registered enrollment: 725
Registry id: NCT00808249

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.